In recent years, the dry eye syndrome market is anticipated to grow rapidly during the forecast period. Dry eye illness affects a large percentage of the global population (from middle age to elderly age). According to the World Ageing 2020 estimate, there will be 727 million people aged 65 and up in the year 2020. In 2050, this population is expected to increase to 1.5 billion. From 9.3 percent in 2020 to roughly 16.0 percent in 2050, the proportion of the population aged 65 and up is predicted to rise. The elderly population is expected to grow, and this group will need to be accommodated.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product Type (Tear stimulators, Artificial Tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agent, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose (Unit dose, Multi-dose), Medication Type (Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type (Plastic, Aluminium, Glass), Type (Brands, Generics), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others) – Industry Trends and Forecast to 2032
.
The Global Dry Eye Syndrome Market size was valued at USD 5.19 USD Billion in 2024.
The Global Dry Eye Syndrome Market is projected to grow at a CAGR of 7.3% during the forecast period of 2025 to 2032.
The major players operating in the market include Eli Lilly and Company , AstraZeneca , Novartis AG , Johnson & Johnson Private Limited , Teva Pharmaceutical Industries Ltd., Merck & Co.Inc. , Allergan , Bausch Health Companies Inc. , Abbott , F. Hoffmann-La Roche Ltd. , Pfizer Inc. , GlaxoSmithKline plc , Sanofi , Merck KGaA , Otsuka America PharmaceuticalInc. , Akorn Operating Company LLC , Allostera Pharma Inc. , I-Med Pharma Inc. , Santen Pharmaceuticals Co. Ltd. AFT Pharmaceuticals , Novaliq GmbH .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
